前列腺癌中的PSMA向放射性干疗法:目前的状况和未来的前景
Rahul V Parghane1,2, Sandip Basu1,2
1Radiation Medicine Centre (BARC), Tata Memorial Hospital Annexe, Mumbai, India.
Expert review of anticancer therapy
|August 11, 2023
概括
使用177Lu-PSMA-617的前列腺特异性膜抗原 (PSMA) 向放射性联体疗法 (PRLT) 对转移性割抵抗性前列腺癌 (mCRPC) 显示出有前途. 这种疗法提供了生存益处和改善生活质量,具有有利的安全性.
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 转移性割抵抗性前列腺癌 (mCRPC) 在瘤治疗中提出了重大挑战.
- 前列腺特异性膜抗原 (PSMA) 向的放射性连接体疗法 (PRLT) 已成为一个有前途的治疗方法.
- 在mCRPC患者中,Lu-PSMA-617已经证明了良好的反应率和低毒性生存益处.
研究的目的:
- 审查Lu-PSMA-617 PRLT的指示,患者准备,剂量管理和治疗后的程序.
- 讨论涉及PRLT的前性和后性研究,元分析和临床试验的结果.
- 介绍专家意见和关于PRLT在晚期前列腺癌管理中的作用的未来观点.
主要方法:
- 现有文献的审查,包括前性研究,后性研究,元分析和Lu-PSMA-617的临床试验.
- 讨论患者选择标准,治疗方案,剂量测量和副作用概况.
- 用Lu-PSMA-617治疗的mCRPC患者的生存数据和生活质量改善的分析.
主要成果:
- 在mCRPC患者中,Lu-PSMA-617 PRLT已经显示出良好的结果和出色的安全性.
- 大多数患者的生活质量和生存率都得到了改善.
- 患者的特征,如表现状态和转移部位,会影响生存结果.
结论:
- 卢-PSMA-617是mCRPC第三线治疗的有效和安全替代品,可能比cabazitaxel具有优势.
- 进一步的临床研究正在研究其作为一线或联合疗法,以及转移性激素敏感前列腺癌 (mHSPC) 的使用.
- 目前正在进行的试验有望完善使用PRLT的前列腺癌患者的治疗策略.
关键词:
177Lu-PSMA-61717 这是一个很好的方法.针对PSMA的向放射性干疗法 (PRLT)前列腺癌是什么意思 前列腺癌是什么意思转移性割抵抗性前列腺癌 (mCRPC) 是一种前列腺特异性膜抗原 (PSMA)他们是天文学家.更多相关视频
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.3K
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.0K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:29Positron Emission Tomography
4.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.3K